Karyopharm Therapeutics Inc. (KPTI)
NASDAQ: KPTI · Real-Time Price · USD
8.38
-0.17 (-1.99%)
At close: Mar 17, 2026, 4:00 PM EDT
8.73
+0.35 (4.20%)
After-hours: Mar 17, 2026, 7:49 PM EDT

Karyopharm Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1541358599385486
Market Cap Growth
129.78%57.98%-14.21%-74.17%-20.84%-57.45%
Enterprise Value
395.92354.99219.75214.18415.88568.93
Last Close Price
8.387.3610.1412.9851.0096.30
PE Ratio
--0.41-0.72-0.69-1.68-3.89
PS Ratio
1.050.920.590.682.452.32
PB Ratio
--0.46-0.46-0.73-23.11-6.10
P/TBV Ratio
-0.31-0.28-0.46-0.73-16.71-6.06
P/FCF Ratio
--1.79-0.67-1.07-2.57-4.53
P/OCF Ratio
--1.79-0.67-1.07-2.57-4.54
EV/Sales Ratio
2.712.431.511.472.652.71
EV/EBITDA Ratio
--3.93-1.85-1.66-2.94-5.84
EV/EBIT Ratio
--3.91-1.84-1.65-2.92-5.79
EV/FCF Ratio
--4.71-1.72-2.31-2.78-5.30
Debt / Equity Ratio
-0.97-0.97-1.31-2.25-18.55-3.91
Debt / EBITDA Ratio
-3.38-3.38-2.25-2.40-2.20-3.22
Debt / FCF Ratio
-4.06-4.06-2.10-3.34-2.08-2.92
Net Debt / Equity Ratio
-0.83-0.83-0.86-0.87-2.03-1.07
Net Debt / EBITDA Ratio
-2.68-2.68-1.34-0.91-0.24-0.87
Net Debt / FCF Ratio
-3.21-3.21-1.25-1.27-0.23-0.79
Asset Turnover
1.071.070.720.490.470.68
Inventory Turnover
1.361.361.541.361.251.01
Quick Ratio
0.980.981.513.144.933.41
Current Ratio
1.121.121.703.375.313.74
Return on Equity (ROE)
81.83%81.83%47.36%186.38%341.65%848.37%
Return on Assets (ROA)
-66.48%-66.48%-58.96%-43.18%-42.77%-31.72%
Return on Invested Capital (ROIC)
535.31%535.31%933.36%-7396.11%-1135.84%-1582.10%
Return on Capital Employed (ROCE)
-204.96%-204.96%-98.26%-55.93%-54.29%-40.57%
Earnings Yield
-127.53%-243.61%-138.07%-144.76%-59.41%-25.70%
FCF Yield
-49.03%-55.92%-149.61%-93.25%-38.88%-22.07%
Buyback Yield / Dilution
-7.06%-7.06%-1.70%-1.13%-1.03%-2.81%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q